Chemical Market Research Report

Introduction Cefuroxime, a widely used second-generation cephalosporin antibiotic, plays a critical role in the global pharmaceutical market. Its broad-spectrum activity against Gram-positive and Gram-negative bacteria ensures widespread demand across therapeutic areas such as respiratory tract infections, urinary tract infections, skin infections, and community-acquired pneumonia. Given its importance, Cefuroxime’s pricing dynamics are closely tied to global healthcare demand, raw material availability, production costs, and broader macroeconomic shifts affecting the pharmaceutical supply chain. In the second quarter (Q2) of 2025, Cefuroxime markets in  North America, Asia-Pacific (APAC), and Europe  exhibited a mixed yet slightly downward trajectory, with all three regions registering average declines of approximately 1.64–1.65%. These subtle downward adjustments reflect a balance between moderate global demand, fluctuating feedstock and intermediate costs, regulatory dynami...